Skip to main content
Screener/Healthcare/Biotechnology

ALNY — Alnylam Pharmaceuticals, Inc.

NASDAQ
$253.87+9.65 (+3.95%)
Nasdaq 100Large CapHealthcareFastest GrowingHigh ROELow Beta
$197.81
$495.55
$244.13
$255.51
EPS (TTM)$4.21
P/E Ratio60.30
Dividend Yield—
Market Cap$32.85B
Volume749K
Prev Close$244.32
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$1.2B$206.0M$1.510.0%17.6%
Q4 '25$1.1B$186.4M$1.3775.6%17.0%
Q3 '25$1.2B$251.1M$1.8484.2%20.1%
Q2 '25$773.7M-$66.3M$-0.5181.5%-8.6%
Q1 '25$594.2M-$57.5M$-0.4488.0%-9.7%
Q4 '24$593.2M-$83.8M$-0.6582.7%-14.1%
Q3 '24$500.9M-$111.6M$-0.8782.9%-22.3%
Q2 '24$659.8M-$16.9M$-0.1389.6%-2.6%
Get Your Daily Market Recap